Physician profile
Joseph Wright Clyde
NPI 1710478698
$1,165.30
in general payments reported to CMS, 2019-2025
8 companies · $1,060 in 2025
The $1,060 reported for 2025 was more than what 84% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $77.09 · 2024: $28.57 · 2025: $1,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $810 · Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $810.11 |
| Food and Beverage | $355.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $946.83 | 2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $59.25 | 2023 | Spaceoar Vue System - 10ml |
| Progenics Pharmaceuticals, INC. | $56.78 | 2025 | |
| Siemens Medical Solutions USA, INC. | $28.57 | 2024 | Truebeam |
| Pfizer INC. | $19.39 | 2025 | |
| Novartis Pharmaceuticals Corporation | $18.69 | 2025 | |
| Abbvie INC. | $17.95 | 2025 | |
| Novocure INC. | $17.84 | 2023 | Optune |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Clyde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.